Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Target Group Inc. (CBDY)
USD0.00
+0.00 (+16.67%)
CA OTC Healthcare Drug Manufacturers - Specialty & Generic
Address
20 Hempstead Drive L8W 2E7
Hamilton, ON, CA
Hamilton, ON, CA
CEO
Anthony Carlo Zarcone
Website
targetgroupinc.ca
IPO
2015-12-28
CIK 1586554 ISIN US87614W1045
Description
Target Group Inc. operates within the Canadian cannabis sector, managing the entire lifecycle from cultivation and processing to the distribution of carefully selected cannabis products for both adult medical and recreational consumers. Their extensive product portfolio encompasses traditional cannabis flower, vaporizer-compatible extract pods, and pre-rolls. They also offer a diverse array of innovative infused products, including K-cup compatible coffee and tea pods, beverages, edibles, and topical applications, in addition to a line of CBD wellness items. A notable proprietary product is "Wisp," a unique single-use, pre-measured pod and vaporizer system designed for consumers seeking to vaporize natural botanical herbs, including cannabis. Target Group holds a collaborative agreement with cGreen, Inc. for the manufacturing and distribution of "True Focus," a patent-pending THC antidote, across the United States, Europe, and the Caribbean regions. Further expanding its reach, the company also maintains distribution, collaboration, and licensing arrangements with Serious Seeds B.V. Originally incorporated in 2013, the entity underwent a name change from Chess Supersite Corporation to Target Group Inc. in July 2018. Its operational base is situated in Hamilton, Canada.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+16.67%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
220.9K
Beta
1.23
Float Shares
554.97M
Free Float %
89.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -23.33% | -23.33% | -23.33% | -8.00% | -1.43% | -8.00% | -31.00% | -58.18% | -90.80% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
DCF (Unlevered)
0.01
+1,256.3%
DCF (Levered)
0.01
+428.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Quality scores
Altman Z-Score
-15.22
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-41.1% Q1'26: -37.2% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%-1,200.0% Q1'26: -350.0% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-29.0% Q1'26: -10.7% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-8.1% Q1'26: +0.0% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%-15.2% ★ Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×1.77× Q1'26: 1.66× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-15 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-14 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-8.84M
OE per share TTM
-0.01
Owner's Yield
-795.95%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
294.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
5
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | The Weinstein Family (2015) Trust | 19.26M | 32.00% | 19.26M | — | 19.26M | — | OO | Canada | 2018-08-13 | ↗ |
| 2 | Blackbridge Capital Growth Fund LLC | 18.20M | 9.00% | 18.20M | — | 18.20M | — | CO | Delaware | 2017-05-25 | ↗ |
| 3 | Chess Supersite Inc. | 5.00M | 65.00% | 5.00M | — | 5.00M | — | CO | Canada | 2015-09-28 | ↗ |
| 4 | Rubin Schindermann | 500.0K | 6.50% | 500.0K | — | 500.0K | — | IN | Canada | 2015-09-29 | ↗ |
| 5 | Alexander Starr | 50.0K | 6.50% | 500.0K | — | 500.0K | — | IN | Canada | 2015-09-28 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
50.0K
Cash buys
—
Cash sales
—
Net activity
-50,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-17 | Schindermann Rubin | — | D-Return | D | Common Stock | 50,000 | 0.02 | 1.0K | 23,077,624 | — | ↗ |
| 2020-08-14 | Schindermann Rubin | — | A-Award | A | Common Stock | 10,000,000 | 0.02 | 180.0K | 23,127,624 | — | ↗ |
| 2020-06-01 | Schindermann Rubin | — | D-Return | D | Common Stock | 162,487 | 0.01 | 1.3K | 13,127,624 | — | ↗ |
| 2020-05-28 | Schindermann Rubin | — | D-Return | D | Common Stock | 4,700 | 0.01 | 47.00 | 13,290,111 | — | ↗ |
| 2020-05-18 | Schindermann Rubin | — | D-Return | D | Common Stock | 124,001 | 0.01 | 992.01 | 13,294,811 | — | ↗ |
| 2020-04-09 | Schindermann Rubin | — | D-Return | D | Common Stock | 120,000 | 0.01 | 960.00 | 13,418,812 | — | ↗ |
| 2020-04-08 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,500 | 0.01 | 804.00 | 13,538,812 | — | ↗ |
| 2020-04-07 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 800.00 | 13,639,312 | — | ↗ |
| 2020-04-06 | Schindermann Rubin | — | D-Return | D | Common Stock | 151,056 | 0.01 | 1.2K | 13,739,312 | — | ↗ |
| 2020-04-03 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 800.00 | 13,890,368 | — | ↗ |
| 2020-04-02 | Schindermann Rubin | — | D-Return | D | Common Stock | 334 | 0.01 | 3.34 | 13,990,368 | — | ↗ |
| 2020-03-31 | Schindermann Rubin | — | D-Return | D | Common Stock | 9,004 | 0.01 | 90.04 | 13,990,702 | — | ↗ |
| 2020-03-30 | Schindermann Rubin | — | D-Return | D | Common Stock | 10,000 | 0.01 | 100.00 | 13,999,706 | — | ↗ |
| 2020-03-26 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 800.00 | 14,009,706 | — | ↗ |
| 2020-03-23 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 800.00 | 14,109,706 | — | ↗ |
| 2020-03-19 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 800.00 | 14,209,706 | — | ↗ |
| 2020-03-06 | Schindermann Rubin | — | D-Return | D | Common Stock | 44,400 | 0.01 | 444.00 | 14,309,706 | — | ↗ |
| 2020-03-02 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 1.0K | 14,354,106 | — | ↗ |
| 2020-02-28 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 1.0K | 14,454,106 | — | ↗ |
| 2020-02-27 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 1.0K | 14,554,106 | — | ↗ |
| 2020-02-26 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 1.0K | 14,654,106 | — | ↗ |
| 2020-02-24 | Schindermann Rubin | — | D-Return | D | Common Stock | 80,000 | 0.01 | 1.0K | 14,754,106 | — | ↗ |
| 2020-02-21 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 1.3K | 14,834,106 | — | ↗ |
| 2020-02-20 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 1.3K | 14,934,106 | — | ↗ |
| 2020-02-19 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 1.3K | 15,034,106 | — | ↗ |
| 2020-02-18 | Schindermann Rubin | — | D-Return | D | Common Stock | 100,000 | 0.01 | 1.3K | 15,134,106 | — | ↗ |
| 2020-02-14 | Schindermann Rubin | — | D-Return | D | Common Stock | 165,000 | 0.01 | 2.0K | 15,234,106 | — | ↗ |
| 2020-02-13 | Schindermann Rubin | — | D-Return | D | Common Stock | 17,000 | 0.01 | 204.00 | 15,399,106 | — | ↗ |
| 2020-02-07 | Schindermann Rubin | — | D-Return | D | Common Stock | 80,000 | 0.01 | 1.0K | 15,416,106 | — | ↗ |
| 2020-02-04 | Schindermann Rubin | — | D-Return | D | Common Stock | 6,100 | 0.02 | 109.80 | 15,496,106 | — | ↗ |
| 2020-01-30 | Schindermann Rubin | — | D-Return | D | Common Stock | 38,100 | 0.02 | 762.00 | 15,502,206 | — | ↗ |
| 2020-01-21 | Schindermann Rubin | — | D-Return | D | Common Stock | 200 | 0.02 | 4.00 | 15,540,306 | — | ↗ |
| 2020-01-14 | Schindermann Rubin | — | D-Return | D | Common Stock | 50,000 | 0.02 | 1.0K | 15,540,506 | — | ↗ |
| 2019-12-20 | KATZMAN BARRY ALAN | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-12-18 | Schindermann Rubin | — | D-Return | D | Common Stock | 25,200 | 0.02 | 504.00 | 15,590,506 | — | ↗ |
| 2019-10-23 | Zarcone Anthony Carlo | — | — | I | Common Stock | 0 | 0.00 | — | 10,259,300 | — | ↗ |
| 2019-10-23 | Niddam Saul | — | — | D | Common Stock | 0 | 0.00 | — | 1,666,667 | — | ↗ |
| 2019-10-23 | Monte Frank Michael | — | — | D | Common Stock | 0 | 0.00 | — | 8,184,104 | — | ↗ |
| 2019-10-11 | Schindermann Rubin | — | D-Return | D | Common Stock | 8,250 | 0.07 | 536.25 | 15,615,706 | — | ↗ |
| 2019-10-10 | Schindermann Rubin | — | D-Return | D | Common Stock | 21,750 | 0.07 | 1.5K | 15,623,956 | — | ↗ |
| 2019-10-09 | Schindermann Rubin | — | D-Return | D | Common Stock | 30,000 | 0.06 | 1.8K | 15,645,706 | — | ↗ |
| 2019-06-14 | Mehrali Azmatali | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-06-12 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 3,000,000 | 0.09 | 270.0K | 15,675,706 | — | ↗ |
| 2019-05-02 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 3,600,000 | 0.05 | 180.0K | 12,675,706 | — | ↗ |
| 2019-04-03 | Starr Sasha | Director / Officer | A-Award | A | Common Stock | 8,234,850 | 0.02 | 164.7K | 17,454,056 | — | ↗ |
| 2019-03-31 | Niddam Saul | — | — | D | Common Stock Purchase Warrants | 1,666,667 | 0.05 | 83.3K | 0 | — | ↗ |
| 2019-03-18 | Starr Sasha | Director / Officer | S-Sale | D | Common Stock | 17,000 | 0.08 | 1.3K | 9,221,706 | — | ↗ |
| 2019-03-15 | Schindermann Rubin | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 13,000 | 0.12 | 1.6K | 9,075,706 | — | ↗ |
| 2019-02-25 | Monte Frank Michael | — | — | D | Common Stock Purchase Warrants | 4,444,400 | 0.05 | 222.2K | 0 | — | ↗ |
| 2019-02-22 | Starr Sasha | Director / Officer | D-Return | D | Preferred Stock | 500,000 | 0.00 | — | 0 | — | ↗ |
| 2019-02-21 | Schindermann Rubin | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 0.11 | 5.3K | 9,088,706 | — | ↗ |
| 2019-02-15 | Schindermann Rubin | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 0.10 | 5.0K | 9,138,706 | — | ↗ |
| 2019-01-25 | Schindermann Rubin | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,165 | 0.10 | 616.50 | 9,188,706 | — | ↗ |
| 2019-01-22 | Schindermann Rubin | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.10 | 2.0K | 9,194,871 | — | ↗ |
| 2019-01-14 | Schindermann Rubin | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 23,835 | 0.10 | 2.4K | 9,214,871 | — | ↗ |
| 2018-08-02 | Weinstein Family (2015) Trust | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 19,257,288 | — | ↗ |
| 2018-03-07 | Starr Sasha | Director / Officer | A-Award | A | Common Stock | 1,764,706 | 0.02 | 30.0K | 9,238,706 | — | ↗ |
| 2018-03-07 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,764,706 | 0.02 | 30.0K | 8,238,706 | — | ↗ |
| 2018-03-07 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,764,706 | 0.02 | 30.0K | 9,238,706 | — | ↗ |
| 2018-02-05 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,000,000 | 0.01 | 12.3K | 7,474,000 | — | ↗ |
| 2018-02-05 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,000,000 | 0.01 | 12.3K | 7,474,000 | — | ↗ |
| 2017-12-07 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,000,000 | 0.02 | 15.0K | 6,474,000 | — | ↗ |
| 2017-12-07 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,000,000 | 0.02 | 15.0K | 6,474,000 | — | ↗ |
| 2017-11-28 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 4,000,000 | 0.01 | 40.0K | 5,474,000 | — | ↗ |
| 2017-11-28 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 4,000,000 | 0.01 | 40.0K | 5,474,000 | — | ↗ |
| 2017-09-07 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,400,000,000 | 0.00 | 140.0K | 1,474,000,000 | — | ↗ |
| 2017-09-07 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,400,000,000 | 0.00 | 140.0K | 1,474,000,000 | — | ↗ |
| 2017-04-04 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 40,000,000 | 0.00 | 108.0K | 74,000,000 | — | ↗ |
| 2017-04-04 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 40,000,000 | 0.00 | 108.0K | 74,000,000 | — | ↗ |
| 2017-03-23 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 20,000,000 | 0.00 | 50.0K | 34,000,000 | — | ↗ |
| 2017-03-23 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 20,000,000 | 0.00 | 50.0K | 34,000,000 | — | ↗ |
| 2016-12-16 | Starr Sasha | Director / Officer | A-Award | A | Preferred stock | 500,000 | 0.00 | — | 500,000 | — | ↗ |
| 2016-12-08 | Starr Alexander | Director / Officer / 10% Owner | J-Other | A | Common Stock | 2,000,000 | 0.00 | — | 14,000,000 | — | ↗ |
| 2016-12-08 | Schindermann Rubin | Director / Officer / 10% Owner | J-Other | D | Common Stock | 2,000,000 | 0.00 | — | 13,500,000 | — | ↗ |
| 2016-12-06 | Starr Sasha | Director / Officer / 10% Owner | A-Award | A | Preferredd Stock | 500,000 | 0.00 | — | 500,000 | — | ↗ |
| 2016-12-06 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Preferred Stock | 500,000 | 0.00 | — | 500,000 | — | ↗ |
| 2016-12-06 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Preferred Stock | 500,000 | 0.00 | — | 500,000 | — | ↗ |
| 2016-07-19 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 5,000,000 | 0.10 | 500.0K | 15,500,000 | — | ↗ |
| 2016-07-19 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 5,000,000 | 0.10 | 500.0K | 15,500,000 | — | ↗ |
| 2015-12-28 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,500,000 | 0.50 | 750.0K | 10,500,000 | — | ↗ |
| 2015-12-28 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,500,000 | 0.50 | 750.0K | 10,500,000 | — | ↗ |
| 2015-11-17 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 5,000,000 | 0.01 | 50.0K | 9,000,000 | — | ↗ |
| 2015-11-17 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 5,000,000 | 0.01 | 50.0K | 10,500,000 | — | ↗ |
| 2015-10-20 | Starr Alexander | Director / Officer / 10% Owner | A-Award | A | Common Stock | 2,000,000 | 0.00 | — | 2,500,000 | — | ↗ |
| 2015-10-20 | Schindermann Rubin | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,500,000 | 0.00 | — | 4,000,000 | — | ↗ |
| 2015-10-20 | Chess Supersite Inc. (Canada) | 10% Owner | S-Sale | D | Common Stock | 3,000,000 | 0.50 | 1.50M | 2,000,000 | — | ↗ |
| 2014-12-31 | McKillop James K | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-07-23 | Starr Alexander | Director / Officer / 10% Owner | — | I | common stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2014-07-23 | Schindermann Rubin | Director / Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2014-07-23 | Chess Supersite Inc. (Canada) | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2014-05-05 | McKillop James K | — | S-Sale | D | common stock | 9,750,000 | 975.00 | 9.51B | 250,000 | — | ↗ |
| 2014-05-05 | CASSIDY JAMES M | — | S-Sale | A | common stock | 9,750,000 | 975.00 | 9.51B | 250,000 | — | ↗ |
| 2013-11-30 | McKillop James K | Director / Officer / 10% Owner | — | D | common stock | 0 | 0.00 | — | 10,000,000 | — | ↗ |
| 2013-11-30 | CASSIDY JAMES M | Director / Officer / 10% Owner | — | D | common s tock | 0 | 0.00 | — | 10,000,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-7.7K
Shares Outstanding
617.03M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anthony Carlo Zarcone | Chief Executive Officer & Director | 109.4K | male |
| Todd D. Sonoga | Head of Investment Community Awareness Efforts | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CBDY
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
